Seasoned electrophysiology commercial leader joins the Company to expand operating capabilities Westport, CT, March 16, 2022 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG […]
Author: Ken Dropiewski
Avive Secures $22 Million in Series A Funding to Advance Intelligent AED and Lifesaving Platform for Out-of-Hospital Cardiac Arrest
Deployment of a Novel 4-Minute City Program that Engages Community Members to Speed AED Response Time, Improve Survival Rates and Focus on Overcoming Socioeconomic Disparities in Healthcare SAN FRANCISCO, March 16, 2022 /PRNewswire/ — Avive Solutions, Inc., developer of an intelligent AED and connected response platform for out-of-hospital cardiac arrest (OHCA) emergencies, today […]
Lark Health Builds AI-Driven Heart Health Program
New Program Will Provide Real-Time Coaching to Support the Prevention and Management of Atherosclerotic Cardiovascular Disease and Coronary Artery Disease MOUNTAIN VIEW, Calif., March 16, 2022 /PRNewswire/ — Lark Health today announced the development of a novel AI-driven program for the prevention and management of atherosclerotic cardiovascular disease (ASCVD) and coronary artery disease (CAD) […]
Circle Cardiovascular Imaging Announces Strategic Growth Investment from Thoma Bravo
Investment to drive future growth and innovation and strengthen market leadership position CALGARY, AB and SAN FRANCISCO, March 16, 2022 /PRNewswire/ — Circle Cardiovascular Imaging Inc. (“Circle CVI”), the global leader in cardiovascular imaging solutions, today announced a strategic growth investment from Thoma Bravo, a leading software investment firm. Thoma Bravo’s partnership is expected […]
Assessing Complex Endovascular Aneurysm Repair
Rosemont, Ill., March 16, 2022 (GLOBE NEWSWIRE) — A retrospective evaluation of 600 fenestrated-branched endovascular aortic repairs for the treatment of complex aneurysms revealed that fewer than one in five patients experienced an intraoperative adverse event (IAE). Thoraco-abdominal aortic aneurysm repair is among the most complex and serious operations in […]
Hyloris reports results for the full year 2021
Added 4 additional innovative product candidates Strong growth in H2 leading to total revenues of €3.1 million (€0.2 million in 2020) Significant expansion of commercial footprint of Maxigesic® IV Tranexamic RTU licensing extended beyond U.S. €50 million in cash and cash equivalents to execute ambitious growth strategy LIÈGE, Belgium, March […]
Solstice Supports the American Heart Association’s Broward Heart Walk
Funds raised by Solstice’s Heart Walk team support the lifesaving work of the American Heart Association. PLANTATION, Fla., March 15, 2022 (GLOBE NEWSWIRE) — Solstice sponsored the finish line at the American Heart Association (AHA) Broward Heart Walk on Sunday, March 13. The Heart Walk, held annually at Nova Southeastern […]
CareDx Brings Together Leading Transplant Experts to Share Latest Advancements in the Field of Xenotransplantation
SOUTH SAN FRANCISCO, Calif., March 16, 2022 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that it will hold a virtual “Xenotransplantation Innovation Day” featuring a […]
Vivasure Medical Announces First Patient Treated in U.S. Early Feasibility Study Evaluating PerQseal+
Study is the first in the U.S. to evaluate the company’s fully absorbable, patch-based percutaneous closure device for large-bore vessels in transcatheter aortic valve replacement GALWAY, Ireland–(BUSINESS WIRE)–Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced that the first patient was treated in a […]
Cardiawave Announces the Success of Its Clinical Trial to Treat Aortic Stenosis Using VALVOSOFT®, Its Disruptive, Non-Invasive, Ultrasound Treatment
The trial with VALVOSOFT® its disruptive, non-invasive, ultrasound treatment was proven to: be safe and feasible provide a sustained repair of the aortic valve improve quality of life of the 34 patients treated PARIS–(BUSINESS WIRE)–Cardiawave SA, a deeptech medical device company that has developed VALVOSOFT® a revolutionary non-invasive medical device to […]



